✦ LIBER ✦

Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase

✍ Scribed by Akiko Akazawa; Isao Sakaida; Shingo Higaki; Yoshitsugu Kubo; Koichi Uchida; Kiwamu Okita

Publisher: Springer Japan
Year: 2002
Tongue: English
Weight: 190 KB
Volume: 37
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s005350200048

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apoptosis in the intestinal mucosa of pa

Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways

✍ Heitor S. P. Souza; Claudio J. A. Tortori; Morgana T. L. Castelo-Branco; Ana Ter 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 556 KB

Hyperinsulinemia in pediatric patients w

Hyperinsulinemia in pediatric patients with chronic kidney disease: the role of tumor necrosis factor-α

✍ Hsiao L. Lai; Janis Kartal; Mark Mitsnefes 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 132 KB

Enhanced Intestinal Expression of the Pr

Enhanced Intestinal Expression of the Proteasome Subunit Low Molecular Mass Polypeptide 2 in Patients with Inflammatory Bowel Disease

✍ Leo R. Fitzpatrick; Jeffrey S. Small; Lisa S. Poritz; Kevin J. McKenna; Walter A 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 616 KB

Differences in the incidence of flares o

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α agents

✍ Braun, J. ;Baraliakos, X. ;Listing, J. ;Davis, J. ;van der Heijde, D. ;Haibel, H 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## Objective Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) are clinically and pathologically linked. Anti–tumor necrosis factor (anti‐TNF) agents are efficacious in treating AS, but not all are equally effective in treating IBD (Crohn's disease [CD] and ulcerative co

Effect of the anti-tumor necrosis factor

Effect of the anti-tumor necrosis factor-α antibody infliximab on the ex vivo mucosal matrix metalloproteinase–proteolytic phenotype in inflammatory bowel disease

✍ Martin J. Meijer; Marij A.C. Mieremet-Ooms; Wim van Duijn; Annie M. van der Zon; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB

## Background: Previous studies have shown an upregulation of matrix metalloproteinases (mmps) in intestinal tissue of patients with inflammatory bowel disease (ibd) and significant clinical improvement after administration of the anti-tnf-a antibody infliximab. the aims of our study were to determ

Ultrasonography as a primary diagnostic

Ultrasonography as a primary diagnostic tool in patients with inflammatory disease and tumors of the small intestine and large bowel

✍ Tayfun Bozkurt; Friederike Richter; Gerd Lux 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 689 KB

## Abstract In 240 patients with predefined indications, the validity of ultrasound imaging as a primary diagnostic procedure was examined prospectively. Ultrasonography revealed normal intestinal findings in 150 patients and pathological lesions in 90 subjects. All patients underwent subsequent en